Canadian Sec - Delayed Quote CAD
BetterLife Pharma Inc. (BETR.CN)
0.0950
+0.0050
+(5.56%)
At close: 3:56:51 PM EDT
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
Operating Cash Flow
-2,257.6940
-2,472.4100
-1,503.5120
-11,202.8200
-7,164.8810
Investing Cash Flow
--
--
--
--
-71.5500
Financing Cash Flow
2,183.8400
2,501.5430
1,335.8890
11,233.5210
4,089.6440
End Cash Position
18.7640
37.3840
8.3070
173.5130
154.7220
Interest Paid Supplemental Data
--
--
--
--
480.6360
Capital Expenditure
--
--
--
--
-96.6150
Issuance of Capital Stock
805
2,201.5430
833.3130
11,440.7050
1,289.3430
Issuance of Debt
1,524.2000
300
--
120
--
Repayment of Debt
--
--
--
-250
-499.9290
Free Cash Flow
-2,257.6940
-2,472.4100
-1,503.5120
-11,202.8200
-7,261.4960
1/31/2021 - 12/19/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TTI.V Thiogenesis Therapeutics, Corp.
0.6200
0.00%
APS.TO Aptose Biosciences Inc.
2.7900
-0.36%
APLI.TO Appili Therapeutics Inc.
0.0300
0.00%
SVA.TO Sernova Biotherapeutics Inc
0.2000
-2.44%
ONC.TO Oncolytics Biotech Inc.
0.7000
-4.11%
GTBP GT Biopharma, Inc.
2.3800
+2.15%
EDSA Edesa Biotech, Inc.
2.3200
-1.28%
SYRS Syros Pharmaceuticals, Inc.
0.0331
+6.77%
STTK Shattuck Labs, Inc.
0.8701
-12.89%
NGEN.V NervGen Pharma Corp.
3.7100
+2.20%